9th October 2018 Content supplied by: bioMérieux (Industry)
ENDOZYME®II GO the Latest Addition to the BioMérieux ENDONEXT™ Range.
The evolution of endotoxin testing continues with ENDOZYME®II GO, the latest member of bioMérieux’s ENDONEXT™ range of endotoxin detection assays based on recombinant horseshoe crab Factor C (rFC).
Applying rFC technology not only eliminates the need to harvest horseshoe crab blood, it makes your entire lab more efficient.
Validated according to USP <1225> and <85>; rFC was recently U.S. FDA-approved for product release of Galcanezumab (Eli Lilly).
ENDOZYME™ II GO:
- Groundbreaking fast.
- Exceptionally consistent.
- So easy to run.
Join BioMérieux on Tuesday 30 October, 2018, for an informative Webinar entitled - Endotoxin testing using recombinant horseshoe crab factor (rFC).
Date Published: 9th October 2018
ENDONEXT™ - The Evolution of
Redefining Quantitative Microbiological Quality Control